Alpine Global Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,078	Closed	-$109K	–	449
2024 Q2	$109K	Buy	+16,078	New	+$109K	0.02%	398
2023 Q3	–	Sell	-10,655	Closed	-$93.2K	–	236
2023 Q2	$93.2K	Buy	+10,655	New	+$93.2K	0.03%	175